相关实验视频

Updated: Sep 14, 2025

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

SF3B1突变通过激活mTOR途径加速了CLL的发展

Bo Zhang¹, Prajish Iyer¹, Meiling Jin¹

¹Department of Systems Biology, City of Hope Comprehensive Cancer Center, Monrovia, China.

|July 22, 2025

概括

SF3B1突变加速慢性淋巴细胞白血病 (CLL) 的进展,特别是在染色体13q删除的情况下. 准RNA拼接和mTOR通路显示出治疗这种激进形式的CLL的前景.

科学领域:

血液学血液学血液学
分子生物学分子生物学
在瘤学瘤学.

背景情况:

SF3B1突变在慢性淋巴细胞白血病 (CLL) 中很常见,并且经常与染色体13q删除 (del(13q)) 一起发生.
这种遗传组合与预后不佳和CLL攻击性增加有关.
虽然del(13q) 在小鼠中启动了CLL,但SF3B1突变在进展中的作用仍在研究中.

研究的目的:

调查SF3B1突变对在del(13q) 存在的情况下CLL进展的影响.
阐明SF3B1突变导致CLL攻击性的分子机制.

主要方法:

产生一种具有B细胞特异性Sf3b1-K700E等位基因与Mdr小鼠 (携带del(13q)) 交叉的小鼠模型.
对RNA剪接变化的分析,特别是Nfatc1.1.的分析.
评估mTOR信号和MYC通路的激活.
在体外和体内对并发RNA剪接和mTOR通路抑制的评估.

主要成果:

同时出现的Sf3b1-K700E和del (((13q) 在小鼠中加速了CLL进展.
Sf3b1-K700E诱导了Nfatc1的替代RNA剪接,激活了mTOR信号和MYC通路.
结合RNA拼接和mTOR途径的抑制导致小鼠CLL模型中的细胞死亡.

结论:

SF3B1突变通过Nfatc1替代拼接激活mTOR途径,从而促进CLL的攻击性.
同时准RNA剪接和mTOR途径为具有SF3B1突变和del(13q) 的CLL患者提供了潜在的治疗策略.

关键词:

血液学血液学血液学白血病 (Leukemias) 是一种癌症.在瘤学瘤学.

更多相关视频

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

相关概念视频

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

PI3K/mTOR/AKT Signaling Pathway

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...